Companies Dominating the Pharmaceutical & Biotechnology Environment Monitoring Landscape
- Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Springer Nature Limited
- Applied Microarrays Inc.
- C D Genomics
- RELX Group
- MilliporeSigma
- QIAGEN
- Agilent Technologies, Inc.
- Danaher Corporation
- Eppendorf SE
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of pharmaceutical & biotechnology environment monitoring is assessed at USD 1.23 billion.
The pharmaceutical & biotechnology environment monitoring market size was valued at USD 1.11 billion in 2024 and is expected to reach USD 2.55 billion by 2037, expanding at around 6.6% CAGR during the forecast period i.e., between 2025-2037. The market growth is due to increased safety-related awareness among researchers in the pharmaceutical sector.
Asia Pacific industry is predicted to hold largest revenue share of 35% by 2037, driven by increasing development and adoption of advanced biotechnology in developing countries.
The major players in the market are Thermo Fisher Scientific Company, Springer Nature Limited, Applied Microarrays Inc., C D Genomics, RELX Group, MilliporeSigma, QIAGEN, Agilent Technologies, Inc., Danaher Corporation, Eppendorf SE
